Dose variations caused by setup errors in intracranial stereotactic radiotherapy: A PRESAGE study

Stereotactic radiotherapy (SRI) requires tight margins around the tumor, thus producing a steep dose gradient between the tumor and the surrounding healthy tissue. Any setup errors might become clinically significant To date, no study has been performed to evaluate the dosimetric variations caused by setup errors with a 3-dimensional dosimeter, the PRESAGE. This research aimed to evaluate the potential effect that setup errors have on the dose distribution of intracranial SRT. Computed tomography (CT) simulation of a CIRS radiosurgery head phantom was performed with 1.25-mm slice thickness. An ideal treatment plan was generated using Brainlab iPlan. A PRESAGE was made for every treatment with and without errors. A prescan using the optical CT scanner was carried out. Before treatment, the phantom was imaged using Brainlab ExacTrac. Actual radiotherapy treatments with and without errors were carried out with the Novalis treatment machine. Postscan was performed with an optical CT scanner to analyze the dose irradiation. The dose variation between treatments with and without errors was determined using a 3-dimensional gamma analysis. Errors are clinically insignificant when the passing ratio of the gamma analysis is 95% and above. Errors were clinically significant when the setup errors exceeded a 0.7-mm translation and a 0.5 degrees rotation. The results showed that a 3-mm translation shift in the superior-inferior (SI), right-left (RL), and anterior-posterior (AP) directions and 2 degrees couch rotation produced a passing ratio of 53.1%. Translational and rotational errors of 1.5 mm and 1 degrees, respectively, generated a passing ratio of 62.2%. Translation shift of 0.7 mm in the directions of SI, RL, and AP and a 0.5 degrees couch rotation produced a passing ratio of 96.2%. Preventing the occurrences of setup errors in intracranial SRI treatment is extremely important as errors greater than 0.7 mm and 0.5 degrees alter the dose distribution. The geometrical displacements affect dose delivery to the tumor and the surrounding normal tissues. (C) American Association of Medical Dosimetrists.